LLY vs MET · P/E 39, rev $22.97B vs P/E 13, rev $38.23B
Eli Lilly and Company (LLY) versus MetLife Inc (MET) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
MetLife Inc (MET) is a insurance - life company listed on US.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported MET revenue for 2026-06-30 was $38.23B. Net income was $1.92B. MET currently screens at market cap $52.16B and trailing P/E 12.7.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Not investment advice. Open the LLY and MET stock pages for the full models.
Not investment advice.